Overview of Next Generation Probiotics For Inflammatory Bowel Disease

Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Genetically modified bacteria have provided a new strategy to release therapeutically operative molecules in the intestine and have grown into promising new therapies for IBD. Current IBD treatments, such as corticosteroids and immunosuppressants, are associated with relevant side effects and a ...

Abstract Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Genetically modified bacteria have provided a new strategy to release therapeutically ...
Key Details About Next Generation Probiotics For Inflammatory Bowel Disease

Li, M. et al. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials 309, 122584 (2024).
In their review titled " Next-generation probiotics for inflammatory bowel disease " Pesce et al have made a commendable effort in their review discussing the new possibilities of probiotics for IBD management or treatment.

PDF Next
Next-generation probiotics could represent the future of personalized medicine in IBD care, allowing patients to be treated in a more tailored manner, through disease -responsive circuits.
Abstract Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Genetically modified bacteria have provided a new strategy to release therapeutically operative molecules in the intestine and have grown into promising new therapies for IBD.

Overview of Next Generation Probiotics For Inflammatory Bowel Disease
Next-generation probiotics (NGPs) represent a transformative advancement in the field of microbiome-based therapies, offering a promising approach to preventing and treating chronic diseases such as diabetes, obesity, cardiovascular diseases , and inflammatory bowel disease (IBD).
Inflammatory bowel disease (IBD) is a chronic, relapsing condition that is often refractory to treatment. Data from the Global Burden of Disease Study (GBD) indicate that the incidence and disease burden of this condition continue to rise globally, posing a significant public health challenge. With advancements in synthetic biology, engineered probiotics constructed using gene-editing tools ...

Engineering probiotics for inflammatory bowel disease
The pathogenesis of inflammatory bowel disease (IBD) is complex and multifactorial, involving intestinal microbiota imbalance, immune system abnormalities, genetic predispositions, and other factors. Therefore, the attainment of a complete cure for IBD through a single therapeutic modality remains a formidable challenge. In recent years, probiotics have received considerable attention in the ...







Abstract Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a prevalent chronic gastrointestinal disorder. Conventional therapies are often limited by adverse effects and suboptimal long-term efficacy. Probiotics have emerged as promising therapeutic alternatives for IBD because of their ability to modulate the gut microbiota, reinforce ...